KE
INSIDER · RTSN · Retension Pharmaceuticals, Inc. · CHIEF EXECUTIVE OFFICER
Keller Eric L.
Every open-market transaction filed under this name, Oct 13 to Oct 13.
Filings
1
1 buy · 0 sells
Bought
$250K
open market, at cost
Sold
—
includes scheduled sales
Buys since
+17.3%
avg move from buy price, 1 priced
Filings
| Traded | Ticker | Company | Role | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|---|---|
| Oct 13 | RTSN | Retension Pharmaceuticals, Inc. | CHIEF EXECUTIVE OFFICER | Buy | 20,800 | $12.00 | $250K | +17.3% |
"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.